Lakefront Biotherapeutics (GLPGF) Tax Rate (2014 - 2026)
Lakefront Biotherapeutics' (GLPGF) quarterly Tax Rate came in at 0.3% in Q2 2026, up 37.0% year-over-year from 0.22% in Q2 2025, and up 159.59% quarter-over-quarter from 0.5% in Q1 2026.
Analysis
Lakefront Biotherapeutics (GLPGF) Tax Rate (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (GLPGF) has reported Tax Rate for 13 consecutive years, with 0.3% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate rose 37.0% year-over-year to 0.3% in Q2 2026; TTM through Jun 2026 was 6.19%, a 630.0% increase from a year earlier, with the FY2025 full-year figure at 6.19%, up 625.0% from the prior year.
- Tax Rate was 0.3% for Q2 2026 at Lakefront Biotherapeutics, up from 0.5% in the prior quarter.
- Over five years, Tax Rate peaked at 95.43% in Q2 2023 and troughed at 3.81% in Q3 2023.
- A 5-year average of 6.05% and a median of 0.02% in 2024 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate surged 9441 bps in 2023 and tumbled 9681 bps in 2024, its largest moves.
- Over 5 years, Tax Rate stood at 0.8% in 2022, then tumbled by 105 bps to 0.04% in 2023, then surged by 109 bps to 0.0% in 2024, then jumped by 188963 bps to 6.17% in 2025, then sank by 95 bps to 0.3% in 2026.
- The last three Tax Rate figures came in at 0.3% (Q2 2026), 0.5% (Q1 2026), and 6.17% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.20 Bn | 198.21 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 181.83 Bn | 178.65 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.47 Bn | 124.61 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.56 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.59 Bn | 56.40 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.65 Bn | 49.51 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.42 Bn | 30.13 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 30.21 Bn | 30.21 Bn | 1.16 Mn | 1.34% |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | 0.30% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.30% |
| Mar 31, 2026 | -0.50% |
| Dec 31, 2025 | 6.17% |
| Sep 30, 2025 | -3.64% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -1.16% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -1.94% |
| Jun 30, 2024 | -1.38% |
| Mar 31, 2024 | 2.48% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -3.81% |
| Jun 30, 2023 | 95.43% |
| Mar 31, 2023 | -1.63% |
| Dec 31, 2022 | 0.80% |
| Sep 30, 2022 | 1.94% |
| Jun 30, 2022 | 1.02% |
| Mar 31, 2022 | 14.88% |
| Dec 31, 2021 | -40.88% |
| Sep 30, 2021 | -0.17% |